These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 4224206

  • 41. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
    Dolowy WC, Schrek R, Henson D, Cornet J, Brown E.
    Nature; 1968 Jun 15; 218(5146):1028-31. PubMed ID: 5656616
    [No Abstract] [Full Text] [Related]

  • 42. The effect of dibromodulcitol (NSC 104800) on intravenously induced cytemia of rats.
    Németh L.
    Neoplasma; 1971 Jun 15; 18(5):533-7. PubMed ID: 5119525
    [No Abstract] [Full Text] [Related]

  • 43. [3 years of polychemotherapy of pleuro-pulmonary cancer. Apropos of 95 cases].
    Migueres J, Jover A, Levy A.
    Poumon Coeur; 1968 Jun 15; 24(1):97-102. PubMed ID: 4968019
    [No Abstract] [Full Text] [Related]

  • 44. Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard.
    Schmid FA, Otter GM, Stock CC.
    Cancer Res; 1980 Mar 15; 40(3):830-3. PubMed ID: 7471099
    [Abstract] [Full Text] [Related]

  • 45. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E.
    Arch Intern Med; 1973 Mar 15; 131(3):439-45. PubMed ID: 4739436
    [No Abstract] [Full Text] [Related]

  • 46. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP, Young RC, Berard CW, DeVita VT.
    Arch Intern Med; 1973 Mar 15; 131(3):388-90. PubMed ID: 4569375
    [No Abstract] [Full Text] [Related]

  • 47. Studies on induced tumour resistance.
    Garvie WH.
    Br J Surg; 1966 Jan 15; 53(1):69-73. PubMed ID: 5901917
    [No Abstract] [Full Text] [Related]

  • 48. [Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers].
    Teichmann B.
    Arzneimittelforschung; 1965 May 15; 15(5):532-4. PubMed ID: 5898339
    [No Abstract] [Full Text] [Related]

  • 49. Potential anticancer agents. IV. Nitrogen mustards of methylbenzoic acids.
    Niculescu-Duvăz I, Ionescu M, Cambanis A, Vitan M, Feyns V.
    J Med Chem; 1968 May 15; 11(3):500-3. PubMed ID: 5656486
    [No Abstract] [Full Text] [Related]

  • 50. Potential anticancer agents. XXII. Pharmacological properties of some new triazene derivatives.
    Ionescu D, Neagu V, Dobre V, Niculescu-Duvaz I.
    Neoplasma; 1981 May 15; 28(1):19-26. PubMed ID: 7279057
    [Abstract] [Full Text] [Related]

  • 51. Screening study on Taiwan plants for antitumor activities.
    King ML, Wang CT, Chang CF, Hsu HM, Wang SJ, Hartwell JL, Abbott BJ.
    Cancer Chemother Rep 2; 1974 Jul 15; 4(3):1-96. PubMed ID: 4842546
    [No Abstract] [Full Text] [Related]

  • 52. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F, Coltman CA.
    Arch Intern Med; 1973 Mar 15; 131(3):362-6. PubMed ID: 4688035
    [No Abstract] [Full Text] [Related]

  • 53. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT, Sawicki WL, Cashmore AR, Bertino JR.
    Cancer Res; 1973 Nov 15; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract] [Full Text] [Related]

  • 54. Cyto-active amino-acids and peptides. 8. Fluorescent derivatives of melphalan and other amno-acids.
    Everett JL, Baker MH, Bergel F.
    J Chem Soc Perkin 1; 1968 Nov 15; 14():1791-2. PubMed ID: 5691109
    [No Abstract] [Full Text] [Related]

  • 55. Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
    Bishop RC.
    Radiol Clin North Am; 1968 Apr 15; 6(1):91-5. PubMed ID: 5652936
    [No Abstract] [Full Text] [Related]

  • 56. Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives.
    Horváth IP, Somfai-Relle S, Hegedüs L, Jarman M.
    Eur J Cancer Clin Oncol; 1982 Jun 15; 18(6):573-7. PubMed ID: 6811281
    [Abstract] [Full Text] [Related]

  • 57. Procarbazine hydrochloride (Matulane) for Hodgkin's disease.
    Med Lett Drugs Ther; 1970 Aug 21; 12(17):72. PubMed ID: 5514228
    [No Abstract] [Full Text] [Related]

  • 58. Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma.
    DeWys WD, Humphreys SR, Goldin A.
    Cancer Chemother Rep; 1968 Feb 21; 52(2):229-42. PubMed ID: 5646850
    [No Abstract] [Full Text] [Related]

  • 59. [Results of local sclerosing therapy in the treatment of Walker 256 carcinosarcoma implanted in the liver].
    De Macedo AR, Faifer JG, Hossne WS.
    Chir Patol Sper; 1979 Oct 21; 27(5):444-55. PubMed ID: 261944
    [No Abstract] [Full Text] [Related]

  • 60. Arthropod antineoplastic agent.
    Pettit GR, Hartwell JL, Wood HB.
    Cancer Res; 1968 Oct 21; 28(10):2168-9. PubMed ID: 5696945
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.